» Articles » PMID: 36124679

Pediatric COVID-19 Health Disparities and Vaccine Equity

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

While most children with coronavirus 2019 (COVID-19) experience mild illness, some are vulnerable to severe disease and develop long-term complications. Children with disabilities, those from lower-income homes, and those from racial and ethnic minority groups are more likely to be hospitalized and to have poor outcomes following an infection. For many of these same children, a wide range of social, economic, and environmental disadvantages have made it more difficult for them to access COVID-19 vaccines. Ensuring vaccine equity in children and decreasing health disparities promotes the common good and serves society as a whole. In this article, we discuss how the pandemic has exposed long-standing injustices in historically marginalized groups and provide a summary of the research describing the disparities associated with COVID-19 infection, severity, and vaccine uptake. Last, we outline several strategies for addressing some of the issues that can give rise to vaccine inequity in the pediatric population.

Citing Articles

COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years.

Yousaf A, Mak J, Gwynn L, Lutrick K, Bloodworth R, Rai R JAMA Netw Open. 2025; 8(2):e2459672.

PMID: 39992656 PMC: 11851240. DOI: 10.1001/jamanetworkopen.2024.59672.


Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic.

Bose-Brill S, Hirabayashi K, Schwimmer E, Pajor N, Rao S, Mejias A Hosp Pediatr. 2024; 14(8):e341-e348.

PMID: 39076115 PMC: 11287060. DOI: 10.1542/hpeds.2023-007132.


Increased disease severity during COVID-19 related hospitalization in black non-hispanic, hispanic and medicaid-insured young children.

Ochapa M, McGrath L, Alfred T, Lopez S, Nepal R Front Pediatr. 2024; 12:1373444.

PMID: 38933493 PMC: 11203089. DOI: 10.3389/fped.2024.1373444.


Characteristics of Pediatric Concussion across Different Mechanisms of Injury in 5 through 12-Year-Olds.

Roby P, McDonald C, Corwin D, Grady M, Master C, Arbogast K J Pediatr. 2024; 274:114157.

PMID: 38901776 PMC: 11499042. DOI: 10.1016/j.jpeds.2024.114157.


Diversity, Equity, and Inclusion, Child Health, and the Pediatric Subspecialty Workforce.

Orr C, Leslie L, Schaechter J, Williams X, Montez K, Deen J Pediatrics. 2024; 153(Suppl 2).

PMID: 38300010 PMC: 10852199. DOI: 10.1542/peds.2023-063678S.


References
1.
Price A, Olson S, Newhams M, Halasa N, Boom J, Sahni L . BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med. 2022; 386(20):1899-1909. PMC: 9006785. DOI: 10.1056/NEJMoa2202826. View

2.
Schoeppe J, Cheadle A, Melton M, Faubion T, Miller C, Matthys J . The Immunity Community: A Community Engagement Strategy for Reducing Vaccine Hesitancy. Health Promot Pract. 2017; 18(5):654-661. DOI: 10.1177/1524839917697303. View

3.
Fleming-Dutra K, Wallace M, Moulia D, Twentyman E, Roper L, Hall E . Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(26):859-868. DOI: 10.15585/mmwr.mm7126e2. View

4.
Jamison A, Quinn S, Freimuth V . "You don't trust a government vaccine": Narratives of institutional trust and influenza vaccination among African American and white adults. Soc Sci Med. 2018; 221:87-94. PMC: 6350921. DOI: 10.1016/j.socscimed.2018.12.020. View

5.
Leidman E, Duca L, Omura J, Proia K, Stephens J, Sauber-Schatz E . COVID-19 Trends Among Persons Aged 0-24 Years - United States, March 1-December 12, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(3):88-94. PMC: 7821770. DOI: 10.15585/mmwr.mm7003e1. View